Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

Abbott NORTHAMPTON ... has achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment ...

Applications are now being accepted for Future Docs, a leadership program of the Chattanooga-Hamilton County Medical Society ...

Abbott EVP Lisa Earnhardt's pay increased 19% to $6.6 million as her medical device group's sales grew by 12%.

It was during the 1920s when the development of Butyn, a butyl alcohol-based anesthetic, marked the beginning of Abbott's long, productive and ground-breaking involvement in the field of anesthesia.

Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new device that will measure both glucose and ketones, potentially serving as a warning ...

Recent advancements in AF ablation have led to the development of the novel pulsed field ablation (PFA) and very High-Powered Short Duration (VHPSD) radiofrequency ablation. PFA utilizes electrical ...

After hours: March 14 at 7:59:08 PM EDT Loading Chart for ABT ...

Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the ...